| Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis TE Martinez, K Mayilsamy, SS Mohapatra, S Mohapatra Viruses 16 (5), 785, 2024 | | 2024 |
| Microparticle compositions for controlled delivery of telmisartan and actinomycin D S Mohapatra, SS Mohapatra, E Markoutsa, AJ Gonzalez, HN Jadhav US Patent 11,951,152, 2024 | | 2024 |
| Composition and method for treating covid-19 S Mohapatra, SS Mohapatra, K Mayilsamy, E Markoutsa, A McGill US Patent App. 18/389,272, 2024 | | 2024 |
| Composition and method for treating covid-19 S Mohapatra, SS Mohapatra, K Mayilsamy, E Markoutsa, A McGill US Patent App. 18/384,528, 2024 | | 2024 |
| Compositions and methods for treating RSV-infections E Markoutsa, S Mohapatra, S Mohapatra US Patent 11,911,481, 2024 | | 2024 |
| 4D-perfused tumoroid-on-a-chip platform for personalized cancer treatment applications S Mohapatra, SS Mohapatra, T Wang US Patent 11,884,906, 2024 | | 2024 |
| EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools MC Howell Jr, R Green, J Cianne, GW Dayhoff, VN Uversky, S Mohapatra, ... Journal of Biomolecular Structure and Dynamics 41 (19), 9808-9827, 2023 | 4 | 2023 |
| Method of targeting oncolytic viruses to tumors SS Mohapatra, S Mohapatra US Patent App. 18/186,869, 2023 | | 2023 |
| Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-19 PR Sanberg, CB Brechot, SS Mohapatra, S Mohapatra US Patent 11,766,429, 2023 | | 2023 |
| Use of oligochitosans and derivatives thereof for neutralizing viral agents S Mohapatra, SS Mohapatra, J Garay, M Hanna, K Mayilsamy US Patent App. 17/914,225, 2023 | | 2023 |
| Method of delivering genes and drugs to a posterior segment of an eye SS Mohapatra, S Mohapatra, E Markoutsa US Patent 11,752,220, 2023 | | 2023 |
| A mouse model of repeated traumatic brain injury-induced hearing impairment: Early cochlear neurodegeneration in the absence of hair cell loss C Penn, K Mayilsamy, XX Zhu, MA Bauer, SS Mohapatra, RD Frisina, ... Hearing Research 436, 108832, 2023 | 1 | 2023 |
| 4D-perfused tumoroid-on-a-chip platform for personalized cancer treatment applications S Mohapatra, SS Mohapatra, T Wang US Patent 11,685,885, 2023 | | 2023 |
| Acetate-encapsulated linolenic acid liposomes reduce SARS-CoV-2 and RSV infection AR McGill, E Markoutsa, K Mayilsamy, R Green, K Sivakumar, ... Viruses 15 (7), 1429, 2023 | 2 | 2023 |
| Withaferin a increases the effectiveness of immune checkpoint blocker for the treatment of non-small cell lung cancer R Khalil, RJ Green, K Sivakumar, P Varandani, S Bharadwaj, ... Cancers 15 (12), 3089, 2023 | 4 | 2023 |
| Multispectral optoacoustic tomography (MSOT): Monitoring neurovascular changes in a mouse repetitive traumatic brain injury model C Penn, C Katnik, J Cuevas, SS Mohapatra, S Mohapatra Journal of Neuroscience Methods 393, 109876, 2023 | 3 | 2023 |
| Method of targeting oncolytic viruses to tumors SS Mohapatra, S Mohapatra US Patent 11,607,426, 2023 | | 2023 |
| SARS-CoV-2 Infection Increases the Gene Expression Profile for Alzheimer's Disease Risk K Mayilsamy, R Green, AR McGill, TE Martinez, B Chandran, LJ Blair, ... Cell Transplantation, 15-16, 2023 | | 2023 |
| Ultrafast-UV Laser Integrating Cavity Mediated Inactivation of a Pathogen D Voronin, S Mohapatra, S Mohapatra, S Ambardar, M Howell, ... US Patent App. 17/850,791, 2022 | | 2022 |
| Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model M Howell, S Bharadwaj, SS Mohapatra, S Mohapatra Immunotherapy with checkpoint inhibitors for non-small cell lung cancer …, 2022 | | 2022 |
